TA
PACB icon

Tiedemann Advisors’s Pacific Biosciences PACB Stock Holding History

Tiedemann Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,700
Closed -$63K – 438
2018
Q3 		$63K Hold
11,700
– – ﹤0.01% 307
2018
Q2 		$42K Hold
11,700
– – ﹤0.01% 293
2018
Q1 		$24K Hold
11,700
– – ﹤0.01% 263
2017
Q4 		$31K Buy
+11,700
New +$41K ﹤0.01% 221
2017
Q2 		– Sell
-11,700
Closed -$60K – 449
2017
Q1 		$60K Hold
11,700
– – 0.01% 389
2016
Q4 		$45K Buy
+11,700
New +$85K ﹤0.01% 322

Other funds holding PACB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return